Stereotactic Radiosurgery (SRS) Dose Selection for < 2 cm Brain Metastases: The Influence of Planned Whole Brain Radiation Therapy (WBRT)

Diana Stripp, MD
University of Pennsylvania Cancer Center
Ultima Vez Modificado: 7 de noviembre del 2001

Share article


English

Presenter: Young, AB
Presenter's Affiliation: Neurosurgery, University of Kentucky, Lexington, KY
Type of Session: Scientific

Background

  • Based on RTOG 9005, 24 Gy as SRS dose for treatment of brain metastases < 2cm has become the national standard for which no additional therapy (e.g. WBRT) was planned.
  • This analysis reviews a single institutional protocol experience utilizing 20 Gy SRS in patients with newly diagnosed and/or recurrent < 2 cm brain metastases.

    Materials and Methods

  • Between 11/92 and 4/00, 96 pts with 234 newly diagnosed (82%) or recurrent (18%) < 2 cm brain metastases were treated with 20 Gy of SRS.
  • 60% received planned WBRT in combination with SRS.

    Results

  • The overall tumor control rates at 8, 13, and 26 months were 98%, 87%, and 73% respectively.
  • On multivariate analysis the most significant indicator of tumor control was the addition of planned WBRT vs no planned WBRT. Patients receiving planned WBRT had a 13 month tumor control rate of 94% as compared to 79% for those not receiving planned WBRT (p = 0.03).
  • Complication: 6% with RTOG grade 3/4 toxicity.

    Author's Conclusions

  • 20 Gy of SRS is highly effective when combined with planned WBRT for pts with brain metastases < 2cm.
  • For patients being treated for recurrences and/or for which WBRT is not planned, metastases should be treated with 24 Gy as determined by RTOG Study 90-05.

    Clinical/Scientific Implications

  • In selected patients with brain metastases, the addition of SRS boost of 20Gy to WBRT is highly effective palliation. In patients without planned WBRT, the SRS dose should remain 24 Gy for brain mets < 2cm.

    Oncolink's ASTRO Coverage made possible by an unrestricted Educational Grant from Bristol-Myers Squibb Oncology and Pharmacia Oncology.

    English
    News
    Surgical resection and whole brain radiation therapy prolongs survival and improves symptoms

    Mar 14, 2011 - Surgical resection and whole brain radiation therapy of gastrointestinal brain metastases is associated with prolonged survival and improved quality of life, but survival is still lower compared to metastases arising from other tumors, according to a review published online Feb. 11 in Cancer.



  • I Wish You Knew

    How cancer patients have changed my life

    View More



    Blogs and Web Chats

    OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




    OncoLink OncoPilot

    Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

    Más información